We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
+2.51%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$11.9B
AUM Growth
-$755M
Cap. Flow
-$1.47B
Cap. Flow %
-12.34%
Top 10 Hldgs %
33.73%
Holding
1,207
New
25
Increased
513
Reduced
317
Closed
41

Top Buys

Rank Stock Value
1
WELL icon
Welltower
WELL
+$281M
2
DOC icon
Healthpeak Properties
DOC
+$233M
3
LSI
Life Storage, Inc.
LSI
+$141M
4
CONE
CyrusOne Inc Common Stock
CONE
+$139M
5
ESS icon
Essex Property Trust
ESS
+$99.1M

Top Sells

Rank Stock Value
1
BXP icon
Boston Properties
BXP
+$240M
2
HST icon
Host Hotels & Resorts
HST
+$190M
3
HR icon
Healthcare Realty
HR
+$160M
4
DLR icon
Digital Realty Trust
DLR
+$157M
5
CCI icon
Crown Castle
CCI
+$153M

Sector Composition

Rank Sector Weight
1 Real Estate 71.54%
2 Technology 3.97%
3 Industrials 3.48%
4 Financials 2.88%
5 Healthcare 2.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AKCA
1001
DELISTED
Akcea Therapeutics Inc
AKCA
$13K ﹤0.01%
368
– –
GHDX
1002
DELISTED
Genomic Health, Inc.
GHDX
$13K ﹤0.01%
192
– –
LAND
1003
Gladstone Land Corp
LAND
$368M
$12K ﹤0.01%
1,000
– –
MEDP icon
1004
Medpace
MEDP
$16.8B
$12K ﹤0.01%
208
– –
AERI
1005
DELISTED
Aerie Pharmaceuticals
AERI
$12K ﹤0.01%
203
– –
MDCO
1006
DELISTED
Medicines Co
MDCO
$12K ﹤0.01%
403
– –
TSRO
1007
DELISTED
TESARO, Inc.
TSRO
$12K ﹤0.01%
301
– –
CBPO
1008
DELISTED
China Biologic Products Holdings, Inc.
CBPO
$12K ﹤0.01%
153
– –
CRSP icon
1009
CRISPR Therapeutics
CRSP
$4.58B
$11K ﹤0.01%
254
– –
FOLD
1010
DELISTED
Amicus Therapeutics
FOLD
$11K ﹤0.01%
919
– –
OPK icon
1011
Opko Health
OPK
$921M
$11K ﹤0.01%
3,091
– –
PCRX icon
1012
Pacira BioSciences
PCRX
$1.02B
$11K ﹤0.01%
224
– –
PTCT icon
1013
PTC Therapeutics
PTCT
$6.37B
$11K ﹤0.01%
229
– –
MNTA
1014
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
$11K ﹤0.01%
422
– –
ONCE
1015
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
$11K ﹤0.01%
204
– –
EVHC
1016
DELISTED
Envision Healthcare Holdings Inc
EVHC
$11K ﹤0.01%
236
+130
+123% +$5.84K
ON icon
1017
PUT
ON Semiconductor
ON
$33.8B
$10K ﹤0.01%
+2,000
New +$42.7K
TBPH icon
1018
Theravance Biopharma
TBPH
$874M
$10K ﹤0.01%
299
– –
WNS
1019
DELISTED
WNS Holdings
WNS
$10K ﹤0.01%
+200
New +$10.2K
XNCR icon
1020
Xencor
XNCR
$1.44B
$10K ﹤0.01%
260
– –
ARNA
1021
DELISTED
Arena Pharmaceuticals Inc
ARNA
$10K ﹤0.01%
217
– –
VER
1022
CALL
DELISTED
VEREIT, Inc.
VER
$10K ﹤0.01%
400
– –
PTLA
1023
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$10K ﹤0.01%
361
– –
ARWR icon
1024
Arrowhead Research
ARWR
$12.1B
$9K ﹤0.01%
477
– –
ATRA icon
1025
Atara Biotherapeutics
ATRA
$71.2M
$9K ﹤0.01%
8
– –
39 40
41
42 43

Similar funds

SAM
Storebrand Asset Management Lysaker, Norway $34.8B AUM 25.49% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
VIA
Vanguard Investments Australia Victoria, Australia $34.6B AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return

Daiwa Securities Group's Q3 2018 Portfolio in Review

As of Q3 2018, Daiwa Securities Group held 1,207 positions worth $11.9B, down 5.9% from $12.7B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Daiwa Securities Group withdrew a net $1.47B in Q3 2018, closing 41 positions and reducing 317 holdings. Its most notable exit was SITE Centers, an estimated $128M position sold in full.

By sector, the portfolio is most concentrated in Real Estate at 72% of assets, down from 73% a quarter earlier, followed by Technology and Industrials.

Against the trend, Daiwa Securities Group opened a new position in Altaba Inc worth $4.33M.

  • Daiwa Securities Group's largest Q3 2018 buy was Altaba Inc: 63,550 shares worth $4.33M.
  • Daiwa Securities Group added most to Welltower in Q3 2018, an estimated $281M increase.
  • Daiwa Securities Group's biggest Q3 2018 reduction was Boston Properties, cutting an estimated $240M.
  • Daiwa Securities Group fully exited SITE Centers in Q3 2018, selling an estimated $128M.
  • Daiwa Securities Group's ten largest holdings make up 34% of its $11.9B portfolio in Q3 2018.
  • Daiwa Securities Group opened 25 new positions and closed 41 in Q3 2018.
  • Daiwa Securities Group's portfolio value fell 5.9% quarter-over-quarter to $11.9B.

Based on Daiwa Securities Group's 13F filing for Q3 2018, filed 1 Nov 2018.